Rate My Professor Serdar Bulun

Bulun's pioneering work discovered the epigenetic basis of endometriosis and introduced aromatase inhibitors as a novel treatment, informing clinical use to decrease lesion growth, inflammation, and pain. He has linked excess estrogen via estrogen receptor-α to skeletal muscle atrophy and inguinal hernia, treatable with aromatase inhibitors, and identified novel mutations in familial excessive estrogen formation syndrome. With over 180 publications in top journals including the New England Journal of Medicine, Nature Medicine, and Proceedings of the National Academy of Sciences, his scholarship has exceeded 36,000 citations. Key works include "Endometriosis" (New England Journal of Medicine, 2009), "Aromatase expression in endometriosis" (Journal of Clinical Endocrinology & Metabolism, 1996), and "Treatment of severe postmenopausal endometriosis with an aromatase inhibitor" (Fertility and Sterility, 1998). Honors include election to the National Academy of Medicine (2015), American Society for Clinical Investigation (2003), NIH MERIT award, American Society of Reproductive Medicine Distinguished Researcher Award, and presidency of the Society for Reproductive Investigation (2015). He serves as editor-in-chief of Seminars in Reproductive Medicine and contributes to the Robert H. Lurie Comprehensive Cancer Center.